Biosimilars are FDA-approved biologics that are similar to a reference medication. This similarity is made possible through a rigorous regulatory process that verifies their safety and efficacy. Proteins, which make up these medications, are complex and can have inherent variability, but the process of creating biosimilars ensures that they are held to the highest standards. Let's work together to promote the use of biosimilars and ensure that our patients receive the best possible care. #biosimilars #FDAapproval #patientcare #medicationoptions
Tim de Gavre is vice president and chief commercial officer, Sandoz.
Link in bio or visit kevinmd.com/podcast
SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
RATE AND REVIEW → https://www.kevinmd.com/rate
FOLLOW ON INSTAGRAM → https://www.instagram.com/kevinphomd
FOLLOW ON TIKTOK → https://www.tiktok.com/@kevinphomd
